About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
https://weizmann-usa.org/news-media/in-the-news/my-intuition-says-teva-will-get-out-of-this/
Oct 09, 2017...
Prof. Michael Sela Photo: Eyal Izhar
“My intuition tells me that Teva will extricate itself,” Professor Michael Sela, who, together with Ruth Arnon and Deborah Teitelbaum, developed Teva’s blockbuster multiple sclerosis treatment Copaxone at the Weizmann Institute, told “Globes” yesterday.
It was Sela’s close friendship with the late Eli Hurvitz, Teva’s legendary CEO, that brought Copaxone to Teva and made the company what it is today. Former Teva CFO, and currently a director of the company, Dan Suesskind has related in the past how Sela spoke to Hurvitz about a potential drug, COP-1, which eventually became Copaxone. “Fortunately, Teva was allowed to look at the drug file for just $50,000. Who knows, maybe if thrifty Eli had been offered the file for $500,000, Copaxone would never have seen the light of day,” Suesskind said.
Apr 06, 2009... REHOVOT, ISRAEL—April 6, 2009—The design of efficient systems, driven by sunlight, for splitting water into hydrogen and oxygen is among the most important challenges facing science today, underpinning the long-term potential of hydrogen as a clean, sustainable fuel. But manmade systems that exist today are very inefficient and often require additional use of sacrificial chemical agents. In this context, it is important to establish new mechanisms by which water splitting can take place.
Feb 17, 2016...
The ability of computers to recognise faces, text and objects has opened up a range of new technologies from smart CCTV to self-driving cars.
But the machines still have some way to go before they will be able to rival human eyes.
Researchers have shown that when it comes to spotting detail, we still have the edge that may prevent computers from taking over from us entirely.
Scientists have found that despite great leaps in artificial intelligence and learning, computer vision is still no match for human eyes when it comes to recognising objects from a tiny part of an image. The pictures above are some of the examples used in the study - are you able to identify the objects in the images above?
May 16, 2016... Between shadowy hackers and powerful government agencies, keeping electronic communication private can sometimes feel like a losing battle. Now chemists have come up with a clever alternative that's a little old-fashioned. They describe in Nature Communications a way to encrypt and send short messages on paper using everyday chemicals as keys, although they admit its usefulness probably has limits.
https://weizmann-usa.org/news-media/in-the-news/steady-metal-hands/
Jan 30, 2019...
A robotic-assisted hysterectomy performed in 2014 at miVIP Surgery Center, in Los Angeles, California.
Pharmaceutical and consumer-goods company Johnson & Johnson (J&J) sees a lot of robotic surgery in its future. “We’re taking an outlook that digital surgery will be an important dynamic for the next five, 10 and 15 years,” chairman Alex Gorsky said during the company’s fourth-quarter earnings call on Jan. 22. The same day, Bloomberg reported that J&J is looking to buy $2 billion medical robotics company Auris Health, which would add to its already-sizable robotics surgery investment; in 2015, for example, J&J partnered with Alphabet’s Verily Life Sciences to create the startup Verb Surgical, focused on robotic-assisted tools for surgeons.
Jul 25, 2012...
Microscope images of cells (l) with and (r) without temporal focusing
REHOVOT, ISRAEL—July 25, 2012—The imaging potential of cutting-edge microscopes will soon be expanded thanks to Weizmann Institute inventions. A licensing agreement for developing these inventions into commercial products has been signed recently between Yeda, Weizmann’s technology transfer arm, and Intelligent Imaging Innovations (3i) in the United States.
https://weizmann-usa.org/news-media/news-releases/science-tips-september-2014/
Sep 29, 2014... How the brain ages is still largely an open question – in part because this organ is mostly insulated from direct contact with other systems in the body, including the blood and immune systems. In research published recently in Science, Weizmann Institute researchers Prof. Michal Schwartz of the Department of Neurobiology and Dr. Ido Amit of the Department of Immunology found evidence of a unique “signature” that may be the “missing link” between cognitive decline and aging. The scientists believe that this discovery may, in the future, lead to treatments that can slow or reverse cognitive decline in older people.
Feb 19, 2006...
Approximately 18.8 million American adults suffer from depression, the leading cause of disability in the United States. Yet only about half the patients who take common medical treatments like antidepressant drugs actually see a therapeutic effect. Moreover, they suffer a broad range of undesirable side effects including weight gain, sexual dysfunction and even suicidal behavior.
Electroconvulsive therapy (ECT) has a far higher success rate, with some 80% of patients responding positively. ECT, however, is a highly invasive treatment involving general anesthesia, with many serious side effects ranging from dizziness and headaches to temporary or even permanent memory impairment.
Feb 04, 2019...
We treasure our hearts: we fill them with love, soothe them when they ache, and keep them powerful with diet and exercise. But sometimes, no matter what, our hearts are affected by illness and disease – and that’s where science can help.
It’s American Heart Month, the perfect time to share with you some of the Weizmann Institute of Science’s remarkable research on the heart. After all, this affects all of us: as the Centers for Disease Control says, heart problems are both common and varied, affect people of all ages, and strike equally across gender and economic borders.
Jun 15, 2015...
NASA/JPL-Caltech/Space Science Institute
Many thunderstorms in Saturn’s atmosphere could be driving the gas giant’s vast polar cyclones, according to new simulations inspired by observations from NASA’s Cassini spacecraft. What’s more, this research could help astronomers study large-scale atmospheric phenomena on exoplanets light-years away.
For decades, the powerful, swirling hurricane-like features at Saturn’s poles have been a mystery – what drives these storms and why do they persist for so long? Associated with these vortexes are “hot-spots” as observed by Cassini.
©2023 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR
